AUTIFONY THERAPEUTICS
Company Overview
Social Media Profiles
About Autifony Therapeutics
Description
Autifony Therapeutics is focused on developing innovative drugs aimed at treating rare central nervous system disorders. Utilizing pioneering scientific approaches, the company strives to address unmet medical needs and improve patient outcomes in the biotechnology and pharmaceuticals sectors.
Specialties
CNS drug development
Kv3 channel modulation
Fragile X syndrome treatment
Rare epilepsy syndromes
Neurodegenerative disorder therapies
Products & Services
Clinical-stage Kv3 modulators
Orphan drug treatments
Neurological disorder therapies
Rare disease medications
Preclinical drug development
Contact Information
No contact information available
Competitors & Similar Companies(8)
AstraZeneca
Greater London, • United Kingdom
Biogen
Massachusetts, • United States
Novartis
Basel-City, • Switzerland
Roche
Basel-City, • Switzerland
Takeda Pharmaceutical Company
Tokyo, • Japan
GSK (GlaxoSmithKline)
Hillingdon, • United Kingdom
Seagen
Neurocrine Biosciences
California, • United States
News & Media
Search Terms:
autifony therapeutics
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Autifony Therapeutics
Where is Autifony Therapeutics located?
The headquarter of Autifony Therapeutics is located in Hertfordshire, England, United Kingdom
What is the official website of Autifony Therapeutics?
The official website of Autifony Therapeutics is https://www.autifony.com
What industry does Autifony Therapeutics belong to?
Autifony Therapeutics belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Autifony Therapeutics?
Autifony Therapeutics specializes in CNS drug development, Kv3 channel modulation, Fragile X syndrome treatment, Rare epilepsy syndromes, Neurodegenerative disorder therapies.
What products and services is Autifony Therapeutics likely to offer?
Autifony Therapeutics offers Clinical-stage Kv3 modulators, Orphan drug treatments, Neurological disorder therapies, Rare disease medications, Preclinical drug development.
Who are the competitors of Autifony Therapeutics?
Competitors of Autifony Therapeutics are AstraZeneca, Biogen, Novartis, Roche, Takeda Pharmaceutical Company, GSK (GlaxoSmithKline), Seagen, Neurocrine Biosciences.
What does Autifony Therapeutics do?
Autifony Therapeutics is focused on developing innovative drugs aimed at treating rare central nervous system disorders. Utilizing pioneering scientific approaches, the company strives to address unmet medical needs and improve patient outcomes in the biotechnology and pharmaceuticals sectors.